Key result
Catheter ablation emerges as an effective first-line therapy for complex tachyarrhythmias in congenital heart disease.
Why the study?
Increasing survival of patients with CHD to adulthood has introduced challenges regarding the late onset of complex arrhythmias.
This review synthesizes the unique structural and electrophysiological mechanisms driving arrhythmias in adult congenital heart disease and outlines the growing role of advanced catheter ablation techniques as standard-of-care therapy.
Answers are grounded in this paper and cite their sources.
Supports ablation as first-line for tachyarrhythmias in adult congenital heart disease; leaves open need for prospective trials to guide practice.
Major advances in pediatric cardiology in recent decades, especially surgical techniques, have resulted in an increasing number of patients with congenital heart disease (CHD) surviving to adulthood. This has generated new challenges, particularly with regards to the late onset of complex arrhythmias. Abnormal anatomy, surgical scarring, chronic hypoxemia, hemodynamic compromise, neuro-hormonal abnormalities, and genetic factors can all contribute to creating a unique substrate for arrhythmia development. This review attempts to synthesize the current state of knowledge spanning the spectrum from underlying mechanisms of arrhythmias in patients with congenital heart disease to current ablative strategies. We discuss existing knowledge gaps and highlight important areas for future research.
No takes yet. Share an insight, caveat, or question.
Waldmann et al. (2022) conducted a review in Congenital Heart Disease with Tachyarrhythmias. Catheter ablation and arrhythmia management was evaluated. Catheter ablation has increasingly emerged as an effective, first-line therapeutic option for managing complex tachyarrhythmias in the growing, aging population of patients with congenital heart disease.
Synapse has enriched 10 related papers. Consider them for comparative context: